Portsmouth, NH According to Sheehan Phinney, Eric Kilchenstein has joined the firm, where he will work primarily out of the firm’s Portsmouth and Manchester, N.H. offices. Kilchenstein’s practice includes commercial real estate
Holliston, MA JLL Capital Markets has closed the $31.4 million sale-leaseback of the 85,000 s/f, manufacturing facility at 220 Hopping Brook Rd.
Boston, MA Marcus & Millichap has promoted John Horowitz to Northeast division manager. Horowitz, a first vice president, most recently served as district manager.
Westborough, MA According to R.W. Holmes, Mastodon Moving LLC has leased a 31,026 s/f industrial lease at 191-195 Flanders Rd.
Boston, MA Newmark has promoted capital markets professionals Edward Maher to executive vice chairman and co-head of capital markets and Matthew Pullen to vice chairman of Newmark’s capital markets group–led by co-head of U.S. Capital Markets Robert Griffin, working closely with co-head of U.S. Capital Markets Kevin Shannon.
Somerville, MA Dennis Kelleher and John Pentore of Horvath & Tremblay completed the sale of 19 Central St., a 30-unit apartment building. The brick asset sold for $14 million and $466,667 per unit.
Boston, MA According to Lincoln Property Company (LPC), the Mass Law Reform Institute (MLRI) has signed an 11-year lease extension and expansion at 40 Court St. Along with their lease extension, MLRI expands their occupancy to 17,560 s/f
Braintree, MA Cushman & Wakefield arranged a long-term, 100,000 s/f lease for Integra LifeSciences, a medical technology company, at 400 Wood Rd. Cushman & Wakefield represented both the tenant and landlord in the transaction.
Newton, MA CoStar Group, Inc. has named the CoStar Power Broker Quarterly Deals winners for the first quarter of 2022. Rob Nahigian,FRICS,SIOR,CRE,MCR of Auburndale Realty Co. came out on top in the list of winners in Portland, ME.
Boston, MA According to JLL, Carolyn Wheatley has joined the firm as an executive vice president of the brokerage team for tenant representation of biotechnology and technology clients. Wheatley will focus on life sciences